Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03854110
Title Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Geistlich Pharma AG
Indications

pancreatic adenocarcinoma

Therapies

Gemcitabine + GP-2250

GP-2250

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.